Thursday, 1 October 2026Updated just now
← Top stories
Expansion● Neutral for Indian equities

Rasayan Labs launches AI-native drug discovery platform at ICT Mumbai

1 source · first seen 12:36 1 Oct · updated 12:36 1 Oct

The brief

Written from 1 report · check the source before you trade
  • Rasayan Labs launched an AI-native drug discovery platform at ICT Mumbai
  • AI-led drug discovery may matter to Indian pharma companies investing in research

Tags on this story

Pick a tag to see all its stories
AI136 todayPharma and healthcare36 today

Linked by the tag Pharma and healthcare

176 stories this week
  1. 1 OctIndia manufacturing PMI hits seven-month high of 55.1 in SeptemberData · 8 sources · HSBC India Manufacturing PMI rose to 55.1, ending a three-month slowdown
  2. 1 OctHospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losersMarket move · 1 source
  3. 1 OctHospital stocks sell-off a buying opportunity or a risk? Here is what analysts adviceMarket move · 1 source · The Supreme Court flagged a case where drugs costing 2,700 to retailers were billed at 27,000 to patients
  4. 1 OctCould Apollo, Fortis, Max Health Face A Profit Hit From Medicine Price Curbs? Jefferies, BofA, Macquarie Weigh InBroker call · 1 source · The Court questioned the spread between medicine purchase prices and MRP
  5. 30 SeptSupreme Court flags hospital cancer-drug markups; hospital stocks lose $2.6 billionLegal · 2 sources · The Supreme Court urged a probe into reports of steep cancer-drug markups by hospitals
All Pharma and healthcare stories →

Read the reports

1 report · earliest 12:36
Economic TimesRasayan Labs launches AI-native drug discovery platform at ICT Mumbai12:36